Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human

Manabu Shibasaki, Scott L. Davis, Jian Cui, David A. Low, David M. Keller, Sylvain Durand, Craig G. Crandall

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Given the large increase in cutaneous vascular conductance (CVC) during whole-body heat stress, this vascular bed is important in the regulation of blood pressure during orthostatic stress. In this thermal state, changes in CVC are reported to be due to withdrawal of active vasodilator activity. The purpose of this study was to identify, contrary to the current line of thinking, whether cutaneous vasoconstrictor neural activity is enhanced and capable of contributing to reductions in CVC during an orthostatic challenge of heat-stressed individuals. Healthy normotensive subjects were pretreated, subcutaneously, with botulinum toxin A (BTX-A) to inhibit the release of neurotransmitters from cutaneous active vasodilator nerves. On the experimental day, microdialysis probes were placed in the BTX-A-treated site and in an adjacent untreated site. In protocol 1, internal temperature was elevated ∼0.7°C, followed by the application of lower body negative pressure (LBNP; -30 mmHg). LBNP reduced CVC at the BTX-A-treated sites (Δ4.2 ± 2.9%max), as well as at the control site (Δ9.8 ± 4.1%max). In protocol 2, after confirming the absence of cutaneous vasodilatation at the BTX-A-treated site during whole-body heating, CVC at this site was elevated to a similar level relative to the control site (55.4 ± 13.4 versus 60.7 ± 10.4%max, respectively) via intradermal administration of isoproterenol prior to LBNP. Similarly, when flow was matched between sites, LBNP reduced CVC at both the BTX-A-treated (Δ15.3 ± 4.6%max) and the control sites (Δ8.8 ± 5.6%max). These data suggest that the cutaneous vasoconstrictor system is engaged and is capable of decreasing CVC during an orthostatic challenge in heat-stressed individuals.

Original languageEnglish (US)
Pages (from-to)953-959
Number of pages7
JournalJournal of Physiology
Volume575
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Dizziness
Vasoconstriction
Hot Temperature
Blood Vessels
Lower Body Negative Pressure
Skin
Type A Botulinum Toxins
Vasoconstrictor Agents
Vasodilator Agents
Microdialysis
Isoproterenol
Vasodilation
Heating
Neurotransmitter Agents
Healthy Volunteers
Blood Pressure
Temperature

ASJC Scopus subject areas

  • Physiology

Cite this

Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human. / Shibasaki, Manabu; Davis, Scott L.; Cui, Jian; Low, David A.; Keller, David M.; Durand, Sylvain; Crandall, Craig G.

In: Journal of Physiology, Vol. 575, No. 3, 09.2006, p. 953-959.

Research output: Contribution to journalArticle

Shibasaki, Manabu ; Davis, Scott L. ; Cui, Jian ; Low, David A. ; Keller, David M. ; Durand, Sylvain ; Crandall, Craig G. / Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human. In: Journal of Physiology. 2006 ; Vol. 575, No. 3. pp. 953-959.
@article{5806d6fd6fc54deb942e763fed260a08,
title = "Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human",
abstract = "Given the large increase in cutaneous vascular conductance (CVC) during whole-body heat stress, this vascular bed is important in the regulation of blood pressure during orthostatic stress. In this thermal state, changes in CVC are reported to be due to withdrawal of active vasodilator activity. The purpose of this study was to identify, contrary to the current line of thinking, whether cutaneous vasoconstrictor neural activity is enhanced and capable of contributing to reductions in CVC during an orthostatic challenge of heat-stressed individuals. Healthy normotensive subjects were pretreated, subcutaneously, with botulinum toxin A (BTX-A) to inhibit the release of neurotransmitters from cutaneous active vasodilator nerves. On the experimental day, microdialysis probes were placed in the BTX-A-treated site and in an adjacent untreated site. In protocol 1, internal temperature was elevated ∼0.7°C, followed by the application of lower body negative pressure (LBNP; -30 mmHg). LBNP reduced CVC at the BTX-A-treated sites (Δ4.2 ± 2.9{\%}max), as well as at the control site (Δ9.8 ± 4.1{\%}max). In protocol 2, after confirming the absence of cutaneous vasodilatation at the BTX-A-treated site during whole-body heating, CVC at this site was elevated to a similar level relative to the control site (55.4 ± 13.4 versus 60.7 ± 10.4{\%}max, respectively) via intradermal administration of isoproterenol prior to LBNP. Similarly, when flow was matched between sites, LBNP reduced CVC at both the BTX-A-treated (Δ15.3 ± 4.6{\%}max) and the control sites (Δ8.8 ± 5.6{\%}max). These data suggest that the cutaneous vasoconstrictor system is engaged and is capable of decreasing CVC during an orthostatic challenge in heat-stressed individuals.",
author = "Manabu Shibasaki and Davis, {Scott L.} and Jian Cui and Low, {David A.} and Keller, {David M.} and Sylvain Durand and Crandall, {Craig G.}",
year = "2006",
month = "9",
doi = "10.1113/jphysiol.2006.112649",
language = "English (US)",
volume = "575",
pages = "953--959",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human

AU - Shibasaki, Manabu

AU - Davis, Scott L.

AU - Cui, Jian

AU - Low, David A.

AU - Keller, David M.

AU - Durand, Sylvain

AU - Crandall, Craig G.

PY - 2006/9

Y1 - 2006/9

N2 - Given the large increase in cutaneous vascular conductance (CVC) during whole-body heat stress, this vascular bed is important in the regulation of blood pressure during orthostatic stress. In this thermal state, changes in CVC are reported to be due to withdrawal of active vasodilator activity. The purpose of this study was to identify, contrary to the current line of thinking, whether cutaneous vasoconstrictor neural activity is enhanced and capable of contributing to reductions in CVC during an orthostatic challenge of heat-stressed individuals. Healthy normotensive subjects were pretreated, subcutaneously, with botulinum toxin A (BTX-A) to inhibit the release of neurotransmitters from cutaneous active vasodilator nerves. On the experimental day, microdialysis probes were placed in the BTX-A-treated site and in an adjacent untreated site. In protocol 1, internal temperature was elevated ∼0.7°C, followed by the application of lower body negative pressure (LBNP; -30 mmHg). LBNP reduced CVC at the BTX-A-treated sites (Δ4.2 ± 2.9%max), as well as at the control site (Δ9.8 ± 4.1%max). In protocol 2, after confirming the absence of cutaneous vasodilatation at the BTX-A-treated site during whole-body heating, CVC at this site was elevated to a similar level relative to the control site (55.4 ± 13.4 versus 60.7 ± 10.4%max, respectively) via intradermal administration of isoproterenol prior to LBNP. Similarly, when flow was matched between sites, LBNP reduced CVC at both the BTX-A-treated (Δ15.3 ± 4.6%max) and the control sites (Δ8.8 ± 5.6%max). These data suggest that the cutaneous vasoconstrictor system is engaged and is capable of decreasing CVC during an orthostatic challenge in heat-stressed individuals.

AB - Given the large increase in cutaneous vascular conductance (CVC) during whole-body heat stress, this vascular bed is important in the regulation of blood pressure during orthostatic stress. In this thermal state, changes in CVC are reported to be due to withdrawal of active vasodilator activity. The purpose of this study was to identify, contrary to the current line of thinking, whether cutaneous vasoconstrictor neural activity is enhanced and capable of contributing to reductions in CVC during an orthostatic challenge of heat-stressed individuals. Healthy normotensive subjects were pretreated, subcutaneously, with botulinum toxin A (BTX-A) to inhibit the release of neurotransmitters from cutaneous active vasodilator nerves. On the experimental day, microdialysis probes were placed in the BTX-A-treated site and in an adjacent untreated site. In protocol 1, internal temperature was elevated ∼0.7°C, followed by the application of lower body negative pressure (LBNP; -30 mmHg). LBNP reduced CVC at the BTX-A-treated sites (Δ4.2 ± 2.9%max), as well as at the control site (Δ9.8 ± 4.1%max). In protocol 2, after confirming the absence of cutaneous vasodilatation at the BTX-A-treated site during whole-body heating, CVC at this site was elevated to a similar level relative to the control site (55.4 ± 13.4 versus 60.7 ± 10.4%max, respectively) via intradermal administration of isoproterenol prior to LBNP. Similarly, when flow was matched between sites, LBNP reduced CVC at both the BTX-A-treated (Δ15.3 ± 4.6%max) and the control sites (Δ8.8 ± 5.6%max). These data suggest that the cutaneous vasoconstrictor system is engaged and is capable of decreasing CVC during an orthostatic challenge in heat-stressed individuals.

UR - http://www.scopus.com/inward/record.url?scp=33748298953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748298953&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2006.112649

DO - 10.1113/jphysiol.2006.112649

M3 - Article

VL - 575

SP - 953

EP - 959

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 3

ER -